A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

By Minnemann T.   Schubert M.   Hübler D.   Gouni-Berthold I.   Freude S.   Schumann C.   Oettel M.   Ernst M.   Mellinger U.   Sommer F.   Krone W.   Jockenhövel F.  

The Aging Male, Vol. 10, Iss. 3, 2007-01 ,pp. : 155-158

Informa Healthcare

Access to resources Recommend Favorite

Oral testosterone undecanoate (Andriol^®) supplement therapy improves the quality of life for men with testosterone deficiency

By Park N. C.   Yan B. Q.   Chung J. M.   Lee K. M.  

The Aging Male, Vol. 6, Iss. 2, 2003-06 ,pp. : 86-93

Informa Healthcare

Access to resources Recommend Favorite

Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone

By Kalinchenko S. Y.   Kozlov G. I.   Gontcharov N. P.   Katsiya G. V.  

The Aging Male, Vol. 6, Iss. 2, 2003-06 ,pp. : 94-99

Informa Healthcare

Access to resources Recommend Favorite

Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study

By Bouloux Pierre M. G.  

The Aging Male, Vol. 16, Iss. 2, 2013-06 ,pp. : 38-47

Informa Healthcare

Access to resources Recommend Favorite

Clinical experience with the new long-acting injectable testosterone undecanoate. Report on the educational symposium on the occasion of the 5th World Congress on the Aging Male, 9-12 February 2006, Salzburg, Austria

By Morales A.   Nieschlag E.   Schubert M.   Yassin A. A.   Zitzmann M.   Oettel M.  

The Aging Male, Vol. 9, Iss. 4, 2006-12 ,pp. : 221-227

Informa Healthcare

Access to resources Recommend Favorite